Masatoshi Kondo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Masatoshi Kondo has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Akira Hachiya
Biological Science Research, Kao Corporation, Odawara, Kanagawa, Japan
1 shared publicationKeigo Kawabata
Biological Science Research, Kao Corporation, Odawara, Kanagawa, Japan
1 shared publicationKohji Sato
Analytical Science Research, Kao Corporation, Odawara, Kanagawa, Japan
1 shared publicationSayuri Yamaguchi
Biological Science Research, Kao Corporation, Odawara, Kanagawa, Japan
1 shared publication- Shintaro Inoue
Department of Cosmetic Health Science, Gifu Pharmaceutical University, Gifu, Japan
1 shared publication Yoshito Takahashi
Biological Science Research, Kao Corporation, Odawara, Kanagawa, Japan
1 shared publication
Latest Publications
- Open Access
- 1 July 2016
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 29 (5) , 541-549
Glutathione maintenance is crucial for survival of melanocytes after exposure to rhododendrol
Summary: Rhododendrol is a phenolic compound that shows a tyrosinase‐dependent toxicity for melanocytes and occasionally induces a vitiligo‐like skin depigmentation. The post‐tyrosinase mechanisms determining melanocyte death or survival, however, are far from clear. Here, we find that rhododendrol treatment leads to a reduction in the levels of cellular glutathione but also induces a cellular antioxidant response that eventually increases glutathione levels. We further find that rhododendrol toxicity is enhanced when glutathione levels are experimentally reduced and alleviated when glutathione levels are increased. Hence, it appears that the size of the preexisting glutathione pool along with the capacity to supply glutathione via the antioxidant response determines whether melanocytes survive or die after rhododendrol exposure. It is conceivable, therefore, that rhododendrol‐induced leukoderma depends on the capacity to maintain appropriate glutathione levels and that enhancement of glutathione levels may preserve a patient's melanocytes and potentially help in repigmentation.
- 1 July 2016
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 29 (5) , 541-549
Open AccessGlutathione maintenance is crucial for survival of melanocytes after exposure to rhododendrol
Summary: Rhododendrol is a phenolic compound that shows a tyrosinase‐dependent toxicity for melanocytes and occasionally induces a vitiligo‐like skin depigmentation. The post‐tyrosinase mechanisms determining melanocyte death or survival, however, are far from clear. Here, we find that rhododendrol treatment leads to a reduction in the levels of cellular glutathione but also induces a cellular antioxidant response that eventually increases glutathione levels. We further find that rhododendrol toxicity is enhanced when glutathione levels are experimentally reduced and alleviated when glutathione levels are increased. Hence, it appears that the size of the preexisting glutathione pool along with the capacity to supply glutathione via the antioxidant response determines whether melanocytes survive or die after rhododendrol exposure. It is conceivable, therefore, that rhododendrol‐induced leukoderma depends on the capacity to maintain appropriate glutathione levels and that enhancement of glutathione levels may preserve a patient's melanocytes and potentially help in repigmentation.